Sanofi pushes for reconsideration in US antitrust case over injectable insulin
MLex Summary: Sanofi-Aventis filed a reply in support of its request for reconsideration on whether Mylan can plead a bundled-discount theory of exclusion based on a bundle of products in the...To view the full article, register now.
Already a subscriber? Click here to view full article